Related Experiment Video
Updated: May 11, 2026
09:35
A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Hyperglycemia in stroke and possible treatments
William A Li1, Shannon Moore-Langston, Tia Chakraborty
1Department of Neurological Surgery, Wayne State University School of Medicine, Detroit, MI, USA.
Neurological Research
|April 30, 2013
Summary
High blood sugar (hyperglycemia) worsens outcomes in acute ischemic stroke patients by damaging brain tissue and increasing inflammation. Further research into these mechanisms is crucial for developing better treatments.
Area of Science:
- Neuroscience
- Endocrinology
- Cardiovascular Medicine
Background:
- Hyperglycemia affects one-third of acute ischemic stroke patients, correlating with poor clinical outcomes.
- Elevated glucose levels are detrimental to penumbral tissue, exacerbating neuronal damage.
- Mechanisms include calcium imbalance, reactive oxygen species (ROS) accumulation, lactic acidosis, and reduced cerebral perfusion.
Purpose of the Study:
- To review the detrimental effects of hyperglycemia on acute ischemic stroke.
- To discuss current and emerging neuroprotective treatments for hyperglycemia in stroke.
- To highlight the need for further research into underlying mechanisms for improved patient outcomes.
Main Methods:
- Review of experimental and clinical stroke studies on hyperglycemia.
- Analysis of the impact of hyperglycemia on neuronal apoptosis, lactic acidosis, and nitric oxide (NO) availability.
- Evaluation of neuroinflammatory responses, including edema and hemorrhage, post-stroke.
Main Results:
- Hyperglycemia intensifies apoptosis, lactic acidosis, and inflammation, leading to edema and hemorrhage.
- Reduced nitric oxide (NO) availability due to hyperglycemia impairs cerebral blood perfusion.
- Previous insulin therapies yielded mixed results; newer trials show promise, but treatments are nascent.
Conclusions:
- Understanding hyperglycemia-induced injuries in stroke is critical for developing targeted neuroprotective strategies.
- Further research into mechanistic pathways is essential for improving functional outcomes in ischemic stroke patients.
- Emerging therapies like glucagon-like protein-1 administration and hyperbaric oxygen require more investigation.
Related Concept Videos
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...